SECUKINUMAB SURVIVAL AND SAFETY BASED ON DEMOGRAPHIC CHARACTERISTICS IN SPONDYLOARTHRITIS AND PSORIASIC ARTHRITIS IN A REAL CLINICAL SETTING.

被引:0
|
作者
Lopez, I. Marta [1 ]
Astigarraga, Uxue [2 ]
Pineiro, Irene [2 ]
Ibarrola, Libe [2 ]
Mendizabal, Javier [2 ]
Sada, Guillen [2 ]
Fito Manteca, Concepcion [2 ]
机构
[1] Hosp Univ Arava, Vitoria, Spain
[2] Hosp Univ Navarra, Pamplona, Spain
关键词
Safety; Secukinumab; Survival;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PANLAR2023
引用
收藏
页码:S105 / S106
页数:2
相关论文
共 50 条
  • [21] Golimumab in real-life settings: 2 Years drug survival and predictors of clinical outcomes in rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis
    Iannone, Florenzo
    Santo, Leonardo
    Anelli, Maria Grazia
    Bucci, Romano
    Semeraro, Angelo
    Quarta, Laura
    D'Onofrio, Francesca
    Marsico, Antonio
    Carlino, Giorgio
    Casilli, Oriana
    Cacciapaglia, Fabio
    Zuccaro, Carmelo
    Falappone, Paola Chiara
    Cantatore, Francesco Paolo
    Muratore, Maurizio
    Lapadula, Giovanni
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2017, 47 (01) : 108 - 114
  • [22] Clinical Characteristics and Treatment Profile of Patients with Psoriatic Arthritis Who Initiated Secukinumab and Other Biologics: Results from the Corrona Psoriatic Arthritis/Spondyloarthritis (PsA/SpA) Registry
    Ogdie, Alexis
    Liu, Mei
    Rebello, Sabrina
    Glynn, Meghan
    Hur, Peter
    Meases, Philip J.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [23] Safety and effectiveness of subcutaneous tocilizumab in patients with rheumatoid arthritis in a real-world clinical setting
    Atsumi, Tatsuya
    Fujio, Keishi
    Yamaoka, Kunihiro
    Tomobe, Minako
    Kuroyanagi, Kazuyuki
    Kameda, Hideto
    MODERN RHEUMATOLOGY, 2018, 28 (05) : 780 - 788
  • [24] NSCLC Patients Harboring ALK Translocation: Clinical Characteristics and Management in Real World Setting. EXPLORE GFPC 02-14
    Monnet, Isabelle
    Auliac, Jean Bernard
    Gervais, Radj
    Chiappa, Anne Marie
    Baize, Nathalie
    Bota, Suzanna
    Doubre, Helene
    Locher, Chrystele
    Bizieux, Acya
    Robinet, Gilles
    Chouaid, Christos
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1161 - S1162
  • [25] Drug Survival, Safety, and Effectiveness of Secukinumab for up to 5 Years in Patients with Psoriasis and Psoriatic Arthritis: A Long-Term Real-Life Experience
    Mastorino, Luca
    Dapavo, Paolo
    Cariti, Caterina
    Susca, Sara
    Siliquini, Niccolo
    Ortoncelli, Michela
    Stroppiana, Elena
    Verrone, Anna
    di Corteranzo, Isotta Giunipero
    Leo, Francesco
    Quaglino, Pietro
    Ribero, Simone
    JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (07):
  • [26] A NOVEL APPROACH TO ASSESS THE DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF IMMUNOGLOBULIN A NEPHROPATHY (IGAN) PATIENTS IN A US REAL-WORLD SETTING
    Przybysz, Raymond
    Mehta, Rina
    Tomas, Gisela Rovira
    Aldworth, Carolina
    Doherty, Jim
    Studer, Rachel
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [27] CLINICAL CHARACTERISTICS AND TREATMENT PROFILES OF PATIENTS WITH ANKYLOSING SPONDYLITIS WHO INITIATED SECUKINUMAB AND OTHER BIOLOGICS: RESULTS FROM THE CORRONA PSORIATIC ARTHRITIS/SPONDYLOARTHRITIS (PSA/SPA) REGISTRY
    Ogdie, Alexis
    Liu, Mei
    Rebello, Sabrina
    Glynn, Meghan
    Mclean, Robert
    Yi, Esther
    Park, Yujin
    Mease, Philip J.
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 484 - 485
  • [28] Clinical Characteristics and Treatment Profiles of Patients with Ankylosing Spondylitis Who Initiated Secukinumab and Other Biologics: Results from the Corrona Psoriatic Arthritis/Spondyloarthritis (PsA/SpA) Registry
    Ogdie, Alexis
    Liu, Mei
    Rebello, Sabrina
    Glynn, Meghan
    Dube, Blessing
    McLean, Robert
    Yi, Esther
    Park, Yujin
    Mease, Philip
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [29] SECUKINUMAB IMPROVES CLINICAL AND PATIENT-REPORTED OUTCOMES AT 6 MONTHS AMONG PATIENTS WITH PSORIATIC ARTHRITIS IN THE US-BASED CORRONA PSORIATIC ARTHRITIS/SPONDYLOARTHRITIS (PSA/SPA) REGISTRY
    Mease, P. J.
    Blachley, T.
    Glynn, M.
    Dube, B.
    Mclean, R.
    Kim, N.
    Hur, P.
    Ogdie, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1165 - 1165
  • [30] Effectiveness and Safety of Secukinumab for Psoriasis in a Real-World Clinical Setting in the Asia-Pacific and Middle East Regions: Results from the REALIA Study
    Foley, Peter
    Tsai, Tsen-Fang
    Rodins, Karl
    Hamadah, Issam Ribhi
    Ammoury, Alfred
    Dayem, Hussein Abdel
    Abdallah, Mahmoud
    Crowe, Susanne
    Haas, Silvia
    Pournara, Effie
    Jagiello, Piotr
    Huang, Yu-Huei
    DERMATOLOGY AND THERAPY, 2022, 12 (02) : 511 - 527